Huron Consulting Group Inc. (NASDAQ:HURN) Shares Sold by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lowered its position in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 4.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 56,896 shares of the business services provider’s stock after selling 2,579 shares during the period. Envestnet Asset Management Inc. owned about 0.32% of Huron Consulting Group worth $8,162,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Franklin Resources Inc. lifted its stake in Huron Consulting Group by 16.4% in the 4th quarter. Franklin Resources Inc. now owns 460,650 shares of the business services provider’s stock valued at $57,240,000 after buying an additional 64,862 shares in the last quarter. Norges Bank purchased a new stake in Huron Consulting Group during the 4th quarter worth $7,427,000. Sunriver Management LLC boosted its position in Huron Consulting Group by 10.7% during the 4th quarter. Sunriver Management LLC now owns 486,597 shares of the business services provider’s stock worth $60,465,000 after purchasing an additional 46,968 shares during the period. Assenagon Asset Management S.A. boosted its position in Huron Consulting Group by 27.4% in the 1st quarter. Assenagon Asset Management S.A. now owns 177,449 shares of the business services provider’s stock valued at $25,455,000 after buying an additional 38,163 shares during the last quarter. Finally, Millennium Management LLC boosted its position in Huron Consulting Group by 58.7% in the 4th quarter. Millennium Management LLC now owns 92,872 shares of the business services provider’s stock valued at $11,540,000 after buying an additional 34,353 shares during the last quarter. Institutional investors and hedge funds own 93.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on HURN. Wall Street Zen cut shares of Huron Consulting Group from a “buy” rating to a “hold” rating in a report on Friday, May 2nd. Wedbush raised their target price on shares of Huron Consulting Group from $150.00 to $165.00 and gave the stock an “outperform” rating in a report on Wednesday, March 26th. William Blair restated an “outperform” rating on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Barrington Research lifted their target price on shares of Huron Consulting Group from $167.00 to $173.00 and gave the company an “outperform” rating in a research note on Monday, May 5th. Finally, Benchmark restated a “buy” rating and set a $165.00 price target on shares of Huron Consulting Group in a report on Wednesday, March 26th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $170.75.

Huron Consulting Group Price Performance

Shares of Huron Consulting Group stock opened at $130.22 on Tuesday. Huron Consulting Group Inc. has a 1-year low of $101.73 and a 1-year high of $155.00. The firm’s 50-day moving average price is $140.28 and its two-hundred day moving average price is $138.03. The stock has a market capitalization of $2.25 billion, a price-to-earnings ratio of 19.52 and a beta of 0.28. The company has a current ratio of 2.08, a quick ratio of 2.08 and a debt-to-equity ratio of 1.14.

Huron Consulting Group (NASDAQ:HURN) last announced its quarterly earnings data on Tuesday, April 29th. The business services provider reported $1.68 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.52. Huron Consulting Group had a net margin of 7.88% and a return on equity of 24.68%. The business had revenue of $404.14 million for the quarter, compared to analyst estimates of $389.27 million. During the same period in the prior year, the business posted $1.23 earnings per share. Huron Consulting Group’s revenue was up 11.2% compared to the same quarter last year. On average, equities analysts predict that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Insider Buying and Selling at Huron Consulting Group

In other news, Director Joy Brown sold 668 shares of the firm’s stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $149.74, for a total transaction of $100,026.32. Following the completion of the sale, the director owned 8,896 shares in the company, valued at approximately $1,332,087.04. This trade represents a 6.98% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John Mccartney sold 500 shares of the firm’s stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $136.74, for a total transaction of $68,370.00. Following the sale, the director owned 51,817 shares of the company’s stock, valued at approximately $7,085,456.58. This represents a 0.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 2,708 shares of company stock worth $377,421 over the last quarter. 2.15% of the stock is currently owned by insiders.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.